Communication


As part of PQMD’s ongoing commitment to building knowledge in the field, we maintain access to a wealth of information resources related to the field of donating and delivering high quality medicines and medical products and services to assist communities suffering from the effects of disasters as well as chronic and devastating diseases.

In addition to PQMD’s Guidelines for Quality Medical Product Donations you can find articles, case studies, scholarly publications, study results, guidelines and advice from local, national, and international organizations, and much more on a variety of topics associated with the work of PQMD and its members.

The issues that can be explored using these resources range from the valuation of donated drugs and services to the delicate art of cross-sector partnerships to lessons learned in disaster response, and go well beyond.

Subscribe to our mailing list

* indicates required
Email Format

COVID-19 Impacts International Aid Organizations

COVID-19 Impacts International Aid Organizations International aid organizations are currently restricting their travel and developing response plans in countries impacted or at-risk for COVID-19. Due to the coronavirus, it will be harder for these organizations to travel in and out of countries that need help. As this

Read more

WHO Declares COVID-19 a Pandemic

WHO Declares COVID-19 a Pandemic The World Health Organization (WHO) has declared COVID-19 a pandemic, the first pandemic caused by a coronavirus. COVID-19 is a viral disease that has now infected almost 120,000 people around the world. WHO Director-General Tedros Adhanom Ghebreyesus is urging countries to make

Read more

The Max Foundation co-authors study confirming excellent survival rate of cancer patients in a medication donation program

The Max Foundation co-authors study confirming excellent survival rate of cancer patients in a medication donation program A new study led by Boston University School of Public Health, The Max Foundation, and Novartis found that patients with chronic myeloid leukemia (CML) and gastrointestinal stromal tumors receiving treatment

Read more